The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability (Q43209084)
Jump to navigation
Jump to search
scientific article published on 23 December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability |
scientific article published on 23 December 2009 |
Statements
1 reference
The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability (English)
1 reference
1 reference
1 reference
Anastasia Pyriochou
1 reference
Anne Stössel
1 reference
Athanassios Giannis
1 reference
Heleni Loutrari
1 reference
Lucia Morbidelli
1 reference
Sandra Filippi
1 reference
Ioannis Vasileiadis
1 reference
Charis Roussos
1 reference
Zongmin Zhou
1 reference
Marina Ziche
1 reference
23 December 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference